table of content
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Transmucosal Drug Delivery Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
1.2.2 Passive Transdermal Drug Delivery
1.2.3 Active Transdermal Drug Delivery
1.3 Market by Application
1.3.1 Global Transmucosal Drug Delivery Market Share by Application: 2017 VS 2021 VS 2028
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Transmucosal Drug Delivery Market Perspective (2017-2028)
2.2 Transmucosal Drug Delivery Growth Trends by Region
2.2.1 Transmucosal Drug Delivery Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Transmucosal Drug Delivery Historic Market Size by Region (2017-2022)
2.2.3 Transmucosal Drug Delivery Forecasted Market Size by Region (2023-2028)
2.3 Transmucosal Drug Delivery Market Dynamics
2.3.1 Transmucosal Drug Delivery Industry Trends
2.3.2 Transmucosal Drug Delivery Market Drivers
2.3.3 Transmucosal Drug Delivery Market Challenges
2.3.4 Transmucosal Drug Delivery Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Transmucosal Drug Delivery Players by Revenue
3.1.1 Global Top Transmucosal Drug Delivery Players by Revenue (2017-2022)
3.1.2 Global Transmucosal Drug Delivery Revenue Market Share by Players (2017-2022)
3.2 Global Transmucosal Drug Delivery Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Transmucosal Drug Delivery Revenue
3.4 Global Transmucosal Drug Delivery Market Concentration Ratio
3.4.1 Global Transmucosal Drug Delivery Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Transmucosal Drug Delivery Revenue in 2021
3.5 Transmucosal Drug Delivery Key Players Head office and Area Served
3.6 Key Players Transmucosal Drug Delivery Product Solution and Service
3.7 Date of Enter into Transmucosal Drug Delivery Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Transmucosal Drug Delivery Breakdown Data by Type
4.1 Global Transmucosal Drug Delivery Historic Market Size by Type (2017-2022)
4.2 Global Transmucosal Drug Delivery Forecasted Market Size by Type (2023-2028)
5 Transmucosal Drug Delivery Breakdown Data by Application
5.1 Global Transmucosal Drug Delivery Historic Market Size by Application (2017-2022)
5.2 Global Transmucosal Drug Delivery Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Transmucosal Drug Delivery Market Size (2017-2028)
6.2 North America Transmucosal Drug Delivery Market Size by Country (2017-2022)
6.3 North America Transmucosal Drug Delivery Market Size by Country (2023-2028)
6.4 United States
6.5 Canada
7 Europe
7.1 Europe Transmucosal Drug Delivery Market Size (2017-2028)
7.2 Europe Transmucosal Drug Delivery Market Size by Country (2017-2022)
7.3 Europe Transmucosal Drug Delivery Market Size by Country (2023-2028)
7.4 Germany
7.5 France
7.6 U.K.
7.7 Italy
7.8 Russia
7.9 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Transmucosal Drug Delivery Market Size (2017-2028)
8.2 Asia-Pacific Transmucosal Drug Delivery Market Size by Country (2017-2022)
8.3 Asia-Pacific Transmucosal Drug Delivery Market Size by Country (2023-2028)
8.4 China
8.5 Japan
8.6 South Korea
8.7 Southeast Asia
8.8 India
8.9 Australia
9 Latin America
9.1 Latin America Transmucosal Drug Delivery Market Size (2017-2028)
9.2 Latin America Transmucosal Drug Delivery Market Size by Country (2017-2022)
9.3 Latin America Transmucosal Drug Delivery Market Size by Country (2023-2028)
9.4 Mexico
9.5 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Transmucosal Drug Delivery Market Size (2017-2028)
10.2 Middle East & Africa Transmucosal Drug Delivery Market Size by Country (2017-2022)
10.3 Middle East & Africa Transmucosal Drug Delivery Market Size by Country (2023-2028)
10.4 Turkey
10.5 Saudi Arabia
10.6 UAE
11 Key Players Profiles
11.1 3M Pharmaceuticals
11.1.1 3M Pharmaceuticals Company Detail
11.1.2 3M Pharmaceuticals Business Overview
11.1.3 3M Pharmaceuticals Transmucosal Drug Delivery Introduction
11.1.4 3M Pharmaceuticals Revenue in Transmucosal Drug Delivery Business (2017-2022)
11.1.5 3M Pharmaceuticals Recent Development
11.2 Acrux Limited
11.2.1 Acrux Limited Company Detail
11.2.2 Acrux Limited Business Overview
11.2.3 Acrux Limited Transmucosal Drug Delivery Introduction
11.2.4 Acrux Limited Revenue in Transmucosal Drug Delivery Business (2017-2022)
11.2.5 Acrux Limited Recent Development
11.3 ALZA Corporation
11.3.1 ALZA Corporation Company Detail
11.3.2 ALZA Corporation Business Overview
11.3.3 ALZA Corporation Transmucosal Drug Delivery Introduction
11.3.4 ALZA Corporation Revenue in Transmucosal Drug Delivery Business (2017-2022)
11.3.5 ALZA Corporation Recent Development
11.4 Antares Pharma, Inc.
11.4.1 Antares Pharma, Inc. Company Detail
11.4.2 Antares Pharma, Inc. Business Overview
11.4.3 Antares Pharma, Inc. Transmucosal Drug Delivery Introduction
11.4.4 Antares Pharma, Inc. Revenue in Transmucosal Drug Delivery Business (2017-2022)
11.4.5 Antares Pharma, Inc. Recent Development
11.5 Apricus BioSciences, Inc
11.5.1 Apricus BioSciences, Inc Company Detail
11.5.2 Apricus BioSciences, Inc Business Overview
11.5.3 Apricus BioSciences, Inc Transmucosal Drug Delivery Introduction
11.5.4 Apricus BioSciences, Inc Revenue in Transmucosal Drug Delivery Business (2017-2022)
11.5.5 Apricus BioSciences, Inc Recent Development
11.6 Aveva Drug Delivery Systems
11.6.1 Aveva Drug Delivery Systems Company Detail
11.6.2 Aveva Drug Delivery Systems Business Overview
11.6.3 Aveva Drug Delivery Systems Transmucosal Drug Delivery Introduction
11.6.4 Aveva Drug Delivery Systems Revenue in Transmucosal Drug Delivery Business (2017-2022)
11.6.5 Aveva Drug Delivery Systems Recent Development
11.7 Corium International, Inc
11.7.1 Corium International, Inc Company Detail
11.7.2 Corium International, Inc Business Overview
11.7.3 Corium International, Inc Transmucosal Drug Delivery Introduction
11.7.4 Corium International, Inc Revenue in Transmucosal Drug Delivery Business (2017-2022)
11.7.5 Corium International, Inc Recent Development
11.8 DURECT Corporation
11.8.1 DURECT Corporation Company Detail
11.8.2 DURECT Corporation Business Overview
11.8.3 DURECT Corporation Transmucosal Drug Delivery Introduction
11.8.4 DURECT Corporation Revenue in Transmucosal Drug Delivery Business (2017-2022)
11.8.5 DURECT Corporation Recent Development
11.9 Generex Biotechnology Corporation
11.9.1 Generex Biotechnology Corporation Company Detail
11.9.2 Generex Biotechnology Corporation Business Overview
11.9.3 Generex Biotechnology Corporation Transmucosal Drug Delivery Introduction
11.9.4 Generex Biotechnology Corporation Revenue in Transmucosal Drug Delivery Business (2017-2022)
11.9.5 Generex Biotechnology Corporation Recent Development
11.10 Inovio Pharmaceuticals, Inc.
11.10.1 Inovio Pharmaceuticals, Inc. Company Detail
11.10.2 Inovio Pharmaceuticals, Inc. Business Overview
11.10.3 Inovio Pharmaceuticals, Inc. Transmucosal Drug Delivery Introduction
11.10.4 Inovio Pharmaceuticals, Inc. Revenue in Transmucosal Drug Delivery Business (2017-2022)
11.10.5 Inovio Pharmaceuticals, Inc. Recent Development
11.11 Lohmann Therapy-Systems Corp (LTS Lohmann Therapie Systeme AG)
11.11.1 Lohmann Therapy-Systems Corp (LTS Lohmann Therapie Systeme AG) Company Detail
11.11.2 Lohmann Therapy-Systems Corp (LTS Lohmann Therapie Systeme AG) Business Overview
11.11.3 Lohmann Therapy-Systems Corp (LTS Lohmann Therapie Systeme AG) Transmucosal Drug Delivery Introduction
11.11.4 Lohmann Therapy-Systems Corp (LTS Lohmann Therapie Systeme AG) Revenue in Transmucosal Drug Delivery Business (2017-2022)
11.11.5 Lohmann Therapy-Systems Corp (LTS Lohmann Therapie Systeme AG) Recent Development
11.12 MedPharm LTD
11.12.1 MedPharm LTD Company Detail
11.12.2 MedPharm LTD Business Overview
11.12.3 MedPharm LTD Transmucosal Drug Delivery Introduction
11.12.4 MedPharm LTD Revenue in Transmucosal Drug Delivery Business (2017-2022)
11.12.5 MedPharm LTD Recent Development
11.13 Mylan, Inc.
11.13.1 Mylan, Inc. Company Detail
11.13.2 Mylan, Inc. Business Overview
11.13.3 Mylan, Inc. Transmucosal Drug Delivery Introduction
11.13.4 Mylan, Inc. Revenue in Transmucosal Drug Delivery Business (2017-2022)
11.13.5 Mylan, Inc. Recent Development
11.14 Nemaura Pharma Ltd
11.14.1 Nemaura Pharma Ltd Company Detail
11.14.2 Nemaura Pharma Ltd Business Overview
11.14.3 Nemaura Pharma Ltd Transmucosal Drug Delivery Introduction
11.14.4 Nemaura Pharma Ltd Revenue in Transmucosal Drug Delivery Business (2017-2022)
11.14.5 Nemaura Pharma Ltd Recent Development
11.15 Nitto Denko Corporation
11.15.1 Nitto Denko Corporation Company Detail
11.15.2 Nitto Denko Corporation Business Overview
11.15.3 Nitto Denko Corporation Transmucosal Drug Delivery Introduction
11.15.4 Nitto Denko Corporation Revenue in Transmucosal Drug Delivery Business (2017-2022)
11.15.5 Nitto Denko Corporation Recent Development
11.16 Noven Pharmaceuticals, Inc.
11.16.1 Noven Pharmaceuticals, Inc. Company Detail
11.16.2 Noven Pharmaceuticals, Inc. Business Overview
11.16.3 Noven Pharmaceuticals, Inc. Transmucosal Drug Delivery Introduction
11.16.4 Noven Pharmaceuticals, Inc. Revenue in Transmucosal Drug Delivery Business (2017-2022)
11.16.5 Noven Pharmaceuticals, Inc. Recent Development
11.17 Pantec Biosolutions AG
11.17.1 Pantec Biosolutions AG Company Detail
11.17.2 Pantec Biosolutions AG Business Overview
11.17.3 Pantec Biosolutions AG Transmucosal Drug Delivery Introduction
11.17.4 Pantec Biosolutions AG Revenue in Transmucosal Drug Delivery Business (2017-2022)
11.17.5 Pantec Biosolutions AG Recent Development
11.18 Tapemark
11.18.1 Tapemark Company Detail
11.18.2 Tapemark Business Overview
11.18.3 Tapemark Transmucosal Drug Delivery Introduction
11.18.4 Tapemark Revenue in Transmucosal Drug Delivery Business (2017-2022)
11.18.5 Tapemark Recent Development
11.19 tesa Labtec GmbH
11.19.1 tesa Labtec GmbH Company Detail
11.19.2 tesa Labtec GmbH Business Overview
11.19.3 tesa Labtec GmbH Transmucosal Drug Delivery Introduction
11.19.4 tesa Labtec GmbH Revenue in Transmucosal Drug Delivery Business (2017-2022)
11.19.5 tesa Labtec GmbH Recent Development
11.20 TEVA Pharmaceutical Industries Ltd.
11.20.1 TEVA Pharmaceutical Industries Ltd. Company Detail
11.20.2 TEVA Pharmaceutical Industries Ltd. Business Overview
11.20.3 TEVA Pharmaceutical Industries Ltd. Transmucosal Drug Delivery Introduction
11.20.4 TEVA Pharmaceutical Industries Ltd. Revenue in Transmucosal Drug Delivery Business (2017-2022)
11.20.5 TEVA Pharmaceutical Industries Ltd. Recent Development
11.21 Zosano Pharma
11.21.1 Zosano Pharma Company Detail
11.21.2 Zosano Pharma Business Overview
11.21.3 Zosano Pharma Transmucosal Drug Delivery Introduction
11.21.4 Zosano Pharma Revenue in Transmucosal Drug Delivery Business (2017-2022)
11.21.5 Zosano Pharma Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
